Close Menu

Beckman Coulter

NEW YORK (GenomeWeb) — Beckman Coulter Diagnostics said this month that it has received CE marking for Veris MDx, its "sample-in, results-out" real-time PCR-based molecular diagnostics system, as well as the platform's first assay, a quantitative viral load test for human cytomegalovirus.

NEW YORK (GenomeWeb) – Beckman Coulter Life Sciences today announced it is acquiring Chinese flow cytometry firms Xitogen Technologies and Cytojene for an undisclosed amount.

The story has been updated to include comments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher said today that its revenues in the fourth quarter rose 6 percent year over year with its Life Sciences & Diagnostics segment leading the way.

NEW YORK (GenomeWeb News) – Goldman Sachs on Monday upgraded shares of Danaher's stock, while it downgraded Waters' shares.

NEW YORK (GenomeWeb News) – GE Healthcare said this week it won a tender offer to exclusively provide next-generation sequencing services to a Karolinksa Institutet research group.

NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences on Thursday announced the acquisition of the flow cytometry business assets of ReaMetrix India for an undisclosed amount.

NEW YORK (GenomeWeb News) – AB Sciex today announced that it is combining its Eksigent chromatography business with the capillary electrophoresis unit of its fellow Danaher stablemate Beckman Coulter.

NEW YORK (GenomeWeb News) – The US Food and Drug Administration this week gave 510(k) clearance to Beckman Coulter's Access AccuTnl+3 troponin l assay for use on the company's Access 2 immunoassay system.

Minneapolis – Thermo Fisher Scientific made a splash at this week's American Society of Mass Spectrometry annual meeting with the launch of its hi-res Fusion instrument (

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.